Clinical trial
Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma
NCT07703735 is registered in ClinicalTrials.gov with Seoung Hoon Kim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma
- Lead sponsor
- Seoung Hoon Kim
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 1, 2012
- Completion date
- December 31, 2026
- Enrollment
- 371 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma (hcc), liver transplantation